A confluence of pressures is forcing many insurance companies to reinvent their traditional operating models. … READ MORE >
Blog
Workforce, population shifts are major hurdles for banks: Spring 2022 outlook
While operational hurdles and economic uncertainty remain top issues for financial institutions moving into a new year, their biggest long-term challenges won’t be low interest rates or inflation. Rather, a transforming workforce and the long-term slowing in population growth are likely the greatest threats. … READ MORE >
Hybrid funds emerge as a growing force in venture capital: Spring 2022 outlook
As interest in venture capital continues to grow, more flexible structures including hybrid funds will emerge to cater to the needs of investors and blur the lines between open-end and closed-end structures. … READ MORE >
Automating compliance management can help firms offset rising costs: Spring 2022 outlook
Developments in technology-based solutions and tools offer many options for financial services companies to streamline their regulatory compliance and risk management programs while offsetting rising costs. … READ MORE >
Financial services industry outlook: Spring 2022
Emerging technologies and major shifts in the U.S. labor landscape are among the most significant forces affecting the financial services industry as we look to spring. … READ MORE >
How construction firms can manage a fractured supply chain
Contractors are telling us that their biggest challenge is getting materials to job sites for installation. Items like structural steel joints, windows and door frames that used to take a couple of days to deliver are now taking months to arrive. … READ MORE >
Clinical trials and life sciences services: Spring 2022 outlook
From COVID-19 clinical trial starts to virtual trials, what’s impacting businesses in the life sciences services sector in 2022? … READ MORE >
Biopharma business outlook: Spring 2022
From approvals to investing, what’s on the horizon for middle market biopharma companies in 2022? … READ MORE >
The need for regulatory framework modernization: Spring 2022 medtech outlook
The number of novel medical devices brought to market continues to grow; keeping up with reviews will remain an ongoing challenge for the FDA. … READ MORE >
Macroeconomic drivers for life sciences: Spring 2022 outlook
For the life sciences ecosystem to continue to thrive, leaders must reevaluate their operating environment and plan for key drivers this year. … READ MORE >